HRI is necessary for Regulation of Globin Translation and Survival of Erythroid Precursors in Iron-Deficiency
Reviewer: Walter F. Sall, MD
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: December 9, 2001
Presenter: An-Ping Han
Presenter's Affiliation: MIT
Type of Session: Plenary
The balanced production of heme and globin chains during erythroid cell development results in the production of 250 million hemoglobin molecules per red blood cell. The production of globin chains is exquisitely regulated to match cellular iron stores, preventing excess globin chain production which can lead to chain precipitation and cell death.
In iron deficient states, globin chain production is down-regulated by mechanisms that have been poorly characterized.
Heme-regulated translational inhibitor (HRI) is a protein highly expressed in erythroid cells. Its tyrosine kinase activity is known to downregulate protein translation. It is hypothesized that HRI may act as a sensor of heme levels balancing globin chain production with intracellular heme concentration.
The physiologic function of HRI was evaluated in this study utilizing HRI knockout mice
Materials and Methods
HRI knockout mice were generated for this study. These are viable and fertile mice with normal baseline red cell characteristics.
Mice were subjected to an iron deficient diet to assess red cell response.
Some mice were treated with phenylhydrazine to test the red cell response to oxidative stress.
On iron deficient diets, wild type mice developed the expected microcytic, hypochromic anemia while knockout mice developed an odd normocytic, hyperchromic anemia with an enlarged spleen, erythroid hyperplasia and increased apoptosis of erythroid precursors.
Heme-independent protein synthesis occurred in HRI knockout mice.
Precipitation of globin chains, similar to that seen in beta thalassemia patients, occurred in HRI knockout mice.
Phenylhydrazine induced hemolysis is lethal to HRI knockout mice but not wild type mice.
Phenylhydrazine testing shows that HRI negative red cells are unable to cope with oxidative stress.
The absence of HRI mediated control of globin chain synthesis led to a disregulation of the mechanism by which red cells balance heme and globin production. HRI funtions to protect red cells during period of iron deficiency.
HRI is responsible for the microcytic and hypochromic phenotype of iron deficiency.
HRI deficiency has not been found in any human disease.
Clinical/Scientific Implications This study presents novel data regarding the molecular control mechanisms responsible for the exquisite control of globin chain synthesis. Though this gene has not been implicated in any human disease, further research may provide breakthroughs applicable to the treatment of thalassemia and other diseases of disordered globin synthesis.
Oncolink's ASH Coverage made possible by an unrestricted Educational Grant from Amgen.